News & Events

AviadoBio CEO Emphasizes Collaborative Approach for Treating FTD

In October, U.K.-based gene therapy company AviadoBio, Ltd., and pharmaceutical company Astellas announced an exclusive option and license agreement for an investigational therapeutic, AVB-101, which is currently in a Phase…

MORE

Dear HelpLine: Types of FTD

Dear HelpLine, My mom was recently diagnosed with FTD, and when I visited your website, I learned that there are several types of FTD. My mom wasn’t diagnosed with a…

MORE

Advancing Hope: AFTD Develops New Gene Therapy Resource

There is more hope now than ever before that researchers will be able to develop a treatment for FTD. Much research is underway to understand FTD better, treat the symptoms,…

MORE

Advancing Hope: Sponsored Testing Programs; opportunities for no-cost genetic testing

Once you have chosen to pursue genetic testing, it can be frustrating to learn that the cost is too high, or insurance will not cover genetic testing. Sponsored testing programs…

MORE

Ferrer Doses First Participant in Phase 2 Study for PSP Treatment

Pharmaceutical company Ferrer announced that it has dosed the first participant in the PROSPER phase 2 clinical trial for an experimental treatment for progressive supranuclear palsy. The ongoing trial seeks…

MORE

Persons with FTD Advisory Council Special Article: Holiday Madness

This article was written by a person with FTD to highlight the challenges of dealing with the holidays with an FTD diagnosis. AFTD hopes care partners and those diagnosed can…

MORE

All in the Family to end FTD: Colonial Electric’s Food for Thought Event Clears More than $1 Million Since Inception

AFTD Board alumnus, Steve Bellwoar, has raised more than $1 million to drive AFTD’s mission in memory of his mother. Patricia “Trish” Bellwoar died in 2021 after living with FTD…

MORE

A Conversation with a Neurologist at Denali Therapeutics

Recently, AFTD had a conversation with members of the Denali Therapeutics team, including Dr. Richard Tsai, to provide insights into their work to develop a therapeutic with Takeda to treat…

MORE